Drugs under FDA review in October include weight-loss drugs from Arena Pharmaceuticals(ARNA) and Vivus(VVUS), a diabetes drug from Amylin Pharmaceuticals(AMLN) and partners, a drug to treat opioid addiction from Alkermes(ALKS) and a treatment for fibromyalgia from Jazz Pharmaceuticals(JAZZ).
“Over two-thirds of adults in the United States are overweight or obese, and over one-third are obese” according to data from the National Health and Nutrition Examination Survey. (NHANES) 2003–2006 and 2007–2008.
Market Data 
Markets 
AI
